|
C12ORF23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.627400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.327800E-02 |
| Normal-vs-Stage2 |
3.524500E-02 |
| Normal-vs-Stage3 |
1.304610E-01 |
| Normal-vs-Stage4 |
1.042820E-01 |
| Stage1-vs-Stage2 |
5.691800E-01 |
| Stage1-vs-Stage3 |
2.647800E-02 |
| Stage1-vs-Stage4 |
5.163300E-03 |
| Stage2-vs-Stage3 |
1.534130E-02 |
| Stage2-vs-Stage4 |
2.320100E-02 |
| Stage3-vs-Stage4 |
6.873400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.050200E-01 |
| Normal-vs-AfricanAmerican |
7.493000E-01 |
| Normal-vs-Asian |
8.455200E-01 |
| Caucasian-vs-AfricanAmerican |
9.612800E-01 |
| Caucasian-vs-Asian |
7.389400E-01 |
| AfricanAmerican-vs-Asian |
7.301600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.327400E-01 |
| Normal-vs-Female |
2.165400E-01 |
| Male-vs-Female |
2.023700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.308800E-01 |
| Normal-vs-Extreme_Weight |
9.624200E-02 |
| Normal-vs-Obese |
3.947400E-01 |
| Normal-vs-Extreme_Obese |
5.257700E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.280200E-01 |
| Normal_Weight-vs-Obese |
2.334800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.356400E-01 |
| Extreme_Weight-vs-Obese |
3.265800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.318400E-01 |
| Obese-vs-Extreme_Obese |
1.389210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.057210E-01 |
| Normal-vs-Age(41-60Yrs) |
4.968000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.105840E-01 |
| Normal-vs-Age(81-100Yrs) |
3.198400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.946100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.702100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.655700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.805700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.948240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.848000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.509600E-01 |
| Normal-VS-Type2 PRCC |
8.015500E-02 |
| Normal-VS-KIRP CIMP |
2.930000E-02 |
| Normal-VS-Unclassified PRCC |
8.244200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.676300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.157900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.134800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.824500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.651190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.946240E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.977600E-01 |
| Normal-vs-N1 |
2.864400E-02 |
| Normal-vs-N2 |
2.765600E-01 |
| N0-vs-N1 |
7.040300E-03 |
| N0-vs-N2 |
1.707850E-01 |
| N1-vs-N2 |
9.389800E-01 |
|
|
